Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexaria Bioscience (LEXX) Finished Goods (2018 - 2019)

Lexaria Bioscience's Finished Goods history spans 2 years, with the latest figure at $41415.0 for Q1 2019.

  • For Q1 2019, Finished Goods changed N/A year-over-year to $41415.0; the TTM value through Feb 2019 reached $41415.0, changed N/A, while the annual FY2018 figure was $9752.0, N/A changed from the prior year.
  • Finished Goods for Q1 2019 was $41415.0 at Lexaria Bioscience, up from $9752.0 in the prior quarter.
  • Across five years, Finished Goods topped out at $41415.0 in Q1 2019 and bottomed at $9752.0 in Q3 2018.